PE20001337A1 - Derivados de 4-oxo-1,4-dihidro-3-quinoleincarboxamidas como agentes antivirales - Google Patents
Derivados de 4-oxo-1,4-dihidro-3-quinoleincarboxamidas como agentes antiviralesInfo
- Publication number
- PE20001337A1 PE20001337A1 PE1999001326A PE00132699A PE20001337A1 PE 20001337 A1 PE20001337 A1 PE 20001337A1 PE 1999001326 A PE1999001326 A PE 1999001326A PE 00132699 A PE00132699 A PE 00132699A PE 20001337 A1 PE20001337 A1 PE 20001337A1
- Authority
- PE
- Peru
- Prior art keywords
- oxo
- quinoleincarboxamide
- chlorobenzyl
- dihydro
- methyl
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- CIEWGZJDEDBECJ-UHFFFAOYSA-N 1-chloro-4-methylbenzene Chemical class [CH2]C1=CC=C(Cl)C=C1 CIEWGZJDEDBECJ-UHFFFAOYSA-N 0.000 abstract 3
- -1 3-HYDROXY-1,1-DIMETHYLPROPYL Chemical class 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical class [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 abstract 1
- 241000701022 Cytomegalovirus Species 0.000 abstract 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 abstract 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 abstract 1
- 208000007514 Herpes zoster Diseases 0.000 abstract 1
- 208000029433 Herpesviridae infectious disease Diseases 0.000 abstract 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UN COMPUESTO DERIVADO DE 4-OXO-1,4-DIHIDRO-3-QUINOLEIN-CARBOXAMIDA DE FORMULA I, DONDE R1 ES ALQUILO C1-C7 OPCIONALMENTE SUSTITUIDO CON OH, NR4R5; R2 ES ALQUILO C1-C7 SUSTITUIDO CON OH, NR4R5; R3 ES H, F, ALCOXILO C1-C7; R4 Y R5 JUNTO CON N FORMAN UN HETEROCICLO DE 5-6 MIEMBROS CON 1-3 N, O, S, EL AZUFRE ESTA SUSTITUIDO POR 1-2 OXIGENO. SON COMPUESTOS PREFERIDOS N-(4-CLOROBENCIL)-6-(3-HIDROXI-1,1-DIMETILPROPIL)-1-METIL-4-OXO-1,4-DIHIDRO-3-QUINOLEINCARBOXAMIDA, N-(4-CLOROBENCIL)-1-METIL-6-(4-MORFOLINILMETIL)-4-OXO-1,4DIHIDRO-3-QUINOLEINCARBOXAMIDA, N-(4-CLOROBENCIL)-1-(2-HIDROXIETIL)-6-(3-HIDROXIPROPIL)-4-OXO-1,4-DIHIDRO-3-QUINOLEINCARBOXAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A COMPUESTOS INTERMEDIOS COMO 2-{[METIL-4-(4-MORFOLINILMETIL)ANILINO]METILEN}MALONATO DE DIETILO, ENTRE OTROS Y A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I INHIBE A LA ADN POLIMERASA Y PUEDE SER UTIL PARA EL TRATAMIENTO DE INFECCIONES POR HERPESVIRUS COMO VIRUS DE HERPES, VARICELA ZOSTER, CITOMEGALOVIRUS
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11511399P | 1999-01-08 | 1999-01-08 | |
| US13839099P | 1999-06-09 | 1999-06-09 | |
| US14061499P | 1999-06-23 | 1999-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001337A1 true PE20001337A1 (es) | 2000-11-23 |
Family
ID=27381602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999001326A PE20001337A1 (es) | 1999-01-08 | 1999-12-28 | Derivados de 4-oxo-1,4-dihidro-3-quinoleincarboxamidas como agentes antivirales |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6248736B1 (es) |
| EP (1) | EP1140851B1 (es) |
| JP (1) | JP2002534417A (es) |
| KR (1) | KR20010101428A (es) |
| CN (1) | CN1132818C (es) |
| AT (1) | ATE275134T1 (es) |
| AU (1) | AU2158300A (es) |
| BR (1) | BR9916781A (es) |
| CA (1) | CA2353634A1 (es) |
| CO (1) | CO5150150A1 (es) |
| CZ (1) | CZ20012458A3 (es) |
| DE (1) | DE69919897T2 (es) |
| EA (1) | EA004043B1 (es) |
| ES (1) | ES2228162T3 (es) |
| HK (1) | HK1041879A1 (es) |
| HU (1) | HUP0105142A3 (es) |
| ID (1) | ID29452A (es) |
| IL (1) | IL144170A0 (es) |
| MY (1) | MY118904A (es) |
| NO (1) | NO320396B1 (es) |
| NZ (1) | NZ512823A (es) |
| PE (1) | PE20001337A1 (es) |
| PL (1) | PL348769A1 (es) |
| PT (1) | PT1140851E (es) |
| SK (1) | SK8312001A3 (es) |
| TR (1) | TR200101893T2 (es) |
| TW (1) | TW593281B (es) |
| WO (1) | WO2000040563A1 (es) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6559145B2 (en) | 2000-07-12 | 2003-05-06 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
| US6730682B2 (en) | 2000-07-12 | 2004-05-04 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
| US6562822B2 (en) | 2000-07-12 | 2003-05-13 | Pharmacia & Upjohn Company | Heterocyle carboxamides as antiviral agents |
| US6682892B2 (en) * | 2000-07-13 | 2004-01-27 | Pharmacia & Upjohn Company | Method for treating herpes viruses |
| US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
| JP2004520424A (ja) | 2001-03-01 | 2004-07-08 | ファルマシア・アンド・アップジョン・カンパニー | 抗ウイルス剤としての置換型キノリンカルボキサミド |
| WO2003020728A1 (en) | 2001-08-30 | 2003-03-13 | Pharmacia & Upjohn Company | 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS |
| AR038294A1 (es) | 2002-01-14 | 2005-01-12 | Upjohn Co | Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales |
| AR038117A1 (es) | 2002-01-14 | 2004-12-29 | Upjohn Co | Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida |
| AR038118A1 (es) | 2002-01-14 | 2004-12-29 | Upjohn Co | Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales |
| AU2003262947A1 (en) * | 2002-08-30 | 2004-03-19 | Pharmacia And Upjohn Company | Method of preventing or treating atherosclerosis or restenosis |
| US20040176366A1 (en) * | 2002-08-30 | 2004-09-09 | Wathen Michael W | Method of preventing or treating atherosclerosis or restenosis |
| TR200401663T1 (tr) | 2002-11-20 | 2005-04-21 | Japan Tobacco Inc. | 4-oksokuinolin bileşiği ve bunun HIV integraz inhibitörü olarak kullanımı. |
| CN100375742C (zh) * | 2002-11-20 | 2008-03-19 | 日本烟草产业株式会社 | 4-氧代喹啉化合物及其用途 |
| CA2530352A1 (en) | 2003-07-24 | 2005-02-03 | Astellas Pharma Inc. | Quinolone derivative or salt thereof |
| MY134672A (en) * | 2004-05-20 | 2007-12-31 | Japan Tobacco Inc | Stable crystal of 4-oxoquinoline compound |
| WO2005113509A1 (en) | 2004-05-20 | 2005-12-01 | Japan Tobacco Inc. | Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| EP2229945A1 (en) | 2004-05-21 | 2010-09-22 | Japan Tobacco, Inc. | Combinations comprising a 4-isoquinolone derivative and anti-HIV agents |
| NZ587547A (en) | 2004-06-24 | 2012-09-28 | Vertex Pharma | Modulators of ATP-Binding Cassette Transporters |
| US20070032522A1 (en) * | 2005-07-01 | 2007-02-08 | Kumar Dange V | Antiviral agents |
| PL3219705T3 (pl) | 2005-12-28 | 2020-08-10 | Vertex Pharmaceuticals Incorporated | Kompozycje farmaceutyczne amorficznych postaci n-[2,4-bis(1,1-dimetyloetylo)-5-hydroksyfenylo]-1,4-dihydro-4-oksochinolino-3-karboksyamidu |
| WO2007089030A1 (en) * | 2006-02-01 | 2007-08-09 | Japan Tobacco Inc. | Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection |
| ES2531190T3 (es) * | 2006-03-06 | 2015-03-11 | Japan Tobacco Inc | Método para producir un compuesto de 4-oxoquinolina |
| DE102008036099B4 (de) | 2008-08-04 | 2014-02-13 | Steag Power Saar Gmbh | Entstickungsanlage |
| NZ624460A (en) | 2009-03-20 | 2015-12-24 | Vertex Pharma | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| WO2011004389A2 (en) | 2009-06-18 | 2011-01-13 | Matrix Laboratories Ltd | An improved process for the preparation of elvitegravir |
| NZ604745A (en) * | 2010-08-27 | 2015-01-30 | Gruenenthal Chemie | Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators |
| IL265430B1 (en) | 2012-02-27 | 2024-04-01 | Vertex Pharma | Pharmaceutical preparations containing a solid dispersion of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide and uses thereof |
| JP6250686B2 (ja) | 2012-10-16 | 2017-12-20 | ヤンセン ファーマシューティカ エヌ．ベー． | Ｒｏｒγｔのヘテロアリール結合させたキノリニルモジュレータ |
| AR093017A1 (es) | 2012-10-16 | 2015-05-13 | Janssen Pharmaceutica Nv | MODULARES DE RORgT DE QUINOLINILO UNIDOS POR METILENO |
| JP6251277B2 (ja) | 2012-10-16 | 2017-12-20 | ヤンセン ファーマシューティカ エヌ．ベー． | ＲＯＲ−ガンマ−ｔのフェニル結合キノリニルモジュレーター |
| ES2770727T3 (es) | 2013-10-15 | 2020-07-02 | Janssen Pharmaceutica Nv | Moduladores de quinilonila enlazados a alquilo de ROR(gamma)t |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| US9624225B2 (en) | 2013-10-15 | 2017-04-18 | Janssen Pharmaceutica Nv | Quinolinyl modulators of RORγt |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| CN107250113B (zh) | 2014-10-07 | 2019-03-29 | 弗特克斯药品有限公司 | 囊性纤维化跨膜传导调节蛋白的调节剂的共晶 |
| AU2019339777B2 (en) | 2018-09-12 | 2022-09-01 | Novartis Ag | Antiviral pyridopyrazinedione compounds |
| JP7417715B2 (ja) | 2019-09-26 | 2024-01-18 | ノバルティス アーゲー | 抗ウイルスピラゾロピリジノン化合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2593810B1 (fr) * | 1986-01-24 | 1988-04-22 | Sanofi Sa | Derives de la quinoleine, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant |
| US4786644A (en) * | 1987-11-27 | 1988-11-22 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryl-3-quinolinecarboxamide |
| US4959363A (en) * | 1989-06-23 | 1990-09-25 | Sterling Drug Inc. | Quinolonecarboxamide compounds, their preparation and use as antivirals. |
| AU8448491A (en) * | 1990-09-07 | 1992-03-30 | Schering Corporation | Antiviral compounds and antihypertensive compounds |
| US5175151A (en) | 1990-09-07 | 1992-12-29 | Schering Corporation | Antiviral compounds and antihypertensive compounds |
| EP0531578B1 (en) | 1991-09-10 | 1995-12-20 | Agfa-Gevaert N.V. | Thermally transferable fluorescent compounds |
| ES2193252T3 (es) * | 1995-08-02 | 2003-11-01 | Darwin Discovery Ltd | Quinolonas y su uso terapeutico. |
| WO1997014682A1 (en) | 1995-10-19 | 1997-04-24 | Takeda Chemical Industries, Ltd. | Quinoline derivatives as gnrh antagonists |
| CA2272565A1 (en) | 1996-11-27 | 1998-06-04 | Du Pont Pharmaceuticals Company | Integrin receptor antagonists |
| CA2309882A1 (en) | 1997-12-22 | 1999-07-01 | Pharmacia & Upjohn Company | 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
-
1999
- 1999-12-17 US US09/465,670 patent/US6248736B1/en not_active Expired - Fee Related
- 1999-12-22 EA EA200100755A patent/EA004043B1/ru not_active IP Right Cessation
- 1999-12-22 SK SK831-2001A patent/SK8312001A3/sk unknown
- 1999-12-22 WO PCT/US1999/027959 patent/WO2000040563A1/en active Search and Examination
- 1999-12-22 DE DE69919897T patent/DE69919897T2/de not_active Expired - Fee Related
- 1999-12-22 NZ NZ512823A patent/NZ512823A/en unknown
- 1999-12-22 PT PT99965907T patent/PT1140851E/pt unknown
- 1999-12-22 HU HU0105142A patent/HUP0105142A3/hu unknown
- 1999-12-22 ID IDW00200101463A patent/ID29452A/id unknown
- 1999-12-22 CN CN998151602A patent/CN1132818C/zh not_active Expired - Fee Related
- 1999-12-22 AU AU21583/00A patent/AU2158300A/en not_active Abandoned
- 1999-12-22 KR KR1020017008641A patent/KR20010101428A/ko not_active Application Discontinuation
- 1999-12-22 AT AT99965907T patent/ATE275134T1/de not_active IP Right Cessation
- 1999-12-22 CZ CZ20012458A patent/CZ20012458A3/cs unknown
- 1999-12-22 IL IL14417099A patent/IL144170A0/xx unknown
- 1999-12-22 JP JP2000592271A patent/JP2002534417A/ja active Pending
- 1999-12-22 CA CA002353634A patent/CA2353634A1/en not_active Abandoned
- 1999-12-22 EP EP99965907A patent/EP1140851B1/en not_active Expired - Lifetime
- 1999-12-22 PL PL99348769A patent/PL348769A1/xx unknown
- 1999-12-22 TR TR2001/01893T patent/TR200101893T2/xx unknown
- 1999-12-22 ES ES99965907T patent/ES2228162T3/es not_active Expired - Lifetime
- 1999-12-22 BR BR9916781-6A patent/BR9916781A/pt not_active Application Discontinuation
- 1999-12-24 MY MYPI99005719A patent/MY118904A/en unknown
- 1999-12-28 PE PE1999001326A patent/PE20001337A1/es not_active Application Discontinuation
- 1999-12-29 CO CO99081336A patent/CO5150150A1/es unknown
-
2000
- 2000-01-07 TW TW089100222A patent/TW593281B/zh not_active IP Right Cessation
-
2001
- 2001-07-06 NO NO20013379A patent/NO320396B1/no unknown
-
2002
- 2002-05-07 HK HK02103436A patent/HK1041879A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MY118904A (en) | 2005-02-28 |
| EA004043B1 (ru) | 2003-12-25 |
| NZ512823A (en) | 2003-10-31 |
| SK8312001A3 (en) | 2001-12-03 |
| US6248736B1 (en) | 2001-06-19 |
| EP1140851B1 (en) | 2004-09-01 |
| CN1132818C (zh) | 2003-12-31 |
| EP1140851A1 (en) | 2001-10-10 |
| CA2353634A1 (en) | 2000-07-13 |
| TW593281B (en) | 2004-06-21 |
| EA200100755A1 (ru) | 2001-12-24 |
| HUP0105142A3 (en) | 2002-05-28 |
| NO20013379D0 (no) | 2001-07-06 |
| PL348769A1 (en) | 2002-06-17 |
| HUP0105142A2 (hu) | 2002-04-29 |
| CO5150150A1 (es) | 2002-04-29 |
| WO2000040563A1 (en) | 2000-07-13 |
| BR9916781A (pt) | 2001-12-04 |
| KR20010101428A (ko) | 2001-11-14 |
| DE69919897D1 (en) | 2004-10-07 |
| NO20013379L (no) | 2001-07-06 |
| NO320396B1 (no) | 2005-11-28 |
| CZ20012458A3 (cs) | 2001-12-12 |
| CN1332729A (zh) | 2002-01-23 |
| ES2228162T3 (es) | 2005-04-01 |
| JP2002534417A (ja) | 2002-10-15 |
| AU2158300A (en) | 2000-07-24 |
| TR200101893T2 (tr) | 2001-11-21 |
| ATE275134T1 (de) | 2004-09-15 |
| DE69919897T2 (de) | 2005-09-08 |
| IL144170A0 (en) | 2002-05-23 |
| HK1041879A1 (en) | 2002-07-26 |
| ID29452A (id) | 2001-08-30 |
| PT1140851E (pt) | 2004-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20001337A1 (es) | Derivados de 4-oxo-1,4-dihidro-3-quinoleincarboxamidas como agentes antivirales | |
| PE20060525A1 (es) | Compuestos heterociclicos como inhibidores de cetp | |
| MX9700130A (es) | 2-(1',2',4',-triazol-3'-iloximetilen)-anilidas y uso como agentes de control de plagas. | |
| ATE264846T1 (de) | Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen | |
| AR072756A2 (es) | Intermediarios para la preparacion; derivados de triazolo[4,5-d]pirimidina, utiles como antitromboticos | |
| DK0622361T3 (da) | Heterocykliske forbindelser som bradykininantagonister | |
| HUT70399A (en) | Quinoline derivatives of mostly leukotriene antagonistic activity and pharmaceutical compositions comprising them | |
| PE20070007A1 (es) | Metodos para sintetizar derivados de 6-alquilaminoquinolina | |
| BR9407711A (pt) | Composto de ciclopeptídeo processo para preparaçao de um composto de ciclopeptídeo e parasiticida | |
| ES2037686T3 (es) | Composiciones acuosas herbicidas de imidazolinona. | |
| PE20011349A1 (es) | 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales | |
| BR8205407A (pt) | Processo para a preparacao de derivados substituidos de fenilsulfonilureias composicoes herbicidas processos para o combate do crescimento indesejado de plantas e para a preparacao de composicoes | |
| MY101880A (en) | Benzoylphenylureas, the preparation thereof and the use thereof in pest control. | |
| AR038156A1 (es) | Compuestos de amidoacetonitrilo, proceso para su preparacion, composicion para controlar los parasitos, y uso de estos compuestos para preparar una composicion farmaceutica | |
| KR940005577A (ko) | 4-이미노퀴놀린, 이의 제조방법 및 이의 용도 | |
| DE69900297T2 (de) | Akarizid und insektizid wirksame, substituierte Pyrimidine und Verfahren zu ihrer Herstellung | |
| BR9307288A (pt) | Composto processo para a preparação do mesmo composição herbicida e processo de combate de crescimento de vegetais indesejáveis num local | |
| GB1481919A (en) | Barbituric acid derivatives | |
| PT90106A (pt) | Processo para a preparacao de derivados de avermectina antiparasiticos | |
| DE69928282D1 (de) | Substituierte 1,3,5-triazine als herbizide | |
| CA2373665A1 (en) | Substituted thienocycloalk(en)ylamino-1,3,5-triazine | |
| ES2077739T3 (es) | Sulfonilureas herbicidas, procedimientos y productos intermedios para su obtencion y su empleo. | |
| ES2062286T3 (es) | Compuestos arilicos fenilacetonitriloalquilaminoalquil-orto-sustituidos de utilidad como agentes inmunosupresivos. | |
| ES2044877T3 (es) | Nuevos compuestos de quinolinoxi, procedimiento para su preparacion y su utilizacion como antidotos. | |
| ES8406432A1 (es) | Un procedimiento para preparar esteres del acido fenoxifenoxipropionico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |